Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Galecto, Inc. | 250,000 | reported | 23 Mar 2026 | tx 18+653,280−3,666 |
| Spring Bank Pharmaceuticals, Inc. | 18,575 | reported | 20 Nov 2020 | tx 6+68,750−6,425 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 23 Mar 2026 | GRANT_AWARD | Galecto, Inc. | 250,000 | 0.00 USD | deriv |
| 02 Jan 2026 | SALE | Galecto, Inc. | 255 | 21.38 USD | |
| 02 Jan 2026 | EXERCISE | Galecto, Inc. | 680 | — | |
| 02 Jan 2026 | EXERCISE | Galecto, Inc. | 680 | 0.00 USD | deriv |
| 03 Jul 2025 | EXERCISE | Galecto, Inc. | 680 | — | |
| 03 Jul 2025 | SALE | Galecto, Inc. | 260 | 3.39 USD | |
| 03 Jul 2025 | EXERCISE | Galecto, Inc. | 680 | 0.00 USD | deriv |
| 03 Jan 2025 | EXERCISE | Galecto, Inc. | 1,320 | — | |
| 03 Jan 2025 | SALE | Galecto, Inc. | 471 | 5.60 USD | |
| 03 Jan 2025 | EXERCISE | Galecto, Inc. | 1,320 | 0.00 USD | deriv |
| 03 Jan 2025 | GRANT_AWARD | Galecto, Inc. | 6,000 | 0.00 USD | deriv |
| 09 Oct 2024 | GRANT_AWARD | Galecto, Inc. | 15,600 | 0.00 USD | deriv |
| 03 Jan 2024 | GRANT_AWARD | Galecto, Inc. | 100,000 | 0.00 USD | deriv |
| 04 Jan 2023 | GRANT_AWARD | Galecto, Inc. | 80,000 | 0.00 USD | deriv |
| 04 Jan 2022 | GRANT_AWARD | Galecto, Inc. | 75,000 | 0.00 USD | deriv |
| 03 Dec 2021 | PURCHASE | Galecto, Inc. | 2,000 | 2.48 USD | |
| 23 Jun 2021 | PURCHASE | Galecto, Inc. | 2,000 | 4.80 USD | |
| 15 Jun 2021 | GRANT_AWARD | Galecto, Inc. | 120,000 | 0.00 USD | deriv |
| 19 Nov 2020 | EXERCISE | Spring Bank Pharmaceuticals, Inc. | 6,250 | — | |
| 19 Nov 2020 | GRANT_AWARD | Spring Bank Pharmaceuticals, Inc. | 12,500 | — | |
| 20 Nov 2020 | SALE | Spring Bank Pharmaceuticals, Inc. | 175 | 4.76 USD | |
| 19 Nov 2020 | EXERCISE | Spring Bank Pharmaceuticals, Inc. | 6,250 | 0.00 USD | deriv |
| 05 Mar 2020 | GRANT_AWARD | Spring Bank Pharmaceuticals, Inc. | 25,000 | 0.00 USD | deriv |
| 05 Mar 2020 | GRANT_AWARD | Spring Bank Pharmaceuticals, Inc. | 25,000 | 0.00 USD | deriv |